October 22, 2014 3:02 AM ET

Biotechnology

Company Overview of Symphogen A/S

Company Overview

Symphogen A/S, a biopharmaceutical company, develops recombinant antibody mixture therapeutics for the treatment of cancer. Its product, Sym004, targets the human cancer antigen epidermal growth factor receptor (EGFR). The company’s Sym004 is a mixture of two synergistic full-length anti-EGFR antibodies, which bind to two separate non-overlapping epitopes on EGFR. Symphogen A/S was founded in 2000 and is headquartered in Ballerup, Denmark.

Pederstrupvej 93

Ballerup,  2750

Denmark

Founded in 2000

Phone:

45 45 26 50 50

Fax:

45 45 26 50 60

Key Executives for Symphogen A/S

Co-Founder
Age: 58
Chief Financial Officer
Age: 45
Chief Scientific Officer and Medical Officer
Age: 62
Chief Business Officer
Age: 59
Chief Manufacturing Officer
Compensation as of Fiscal Year 2014.

Symphogen A/S Key Developments

Symphogen Relocates to New Headquarters; Names Mads Laustsen to Chief Manufacturing Officer, Effective June 1,2014

Symphogen A/S announced the relocation of its corporate headquarters in Lyngby, outside Copenhagen, Denmark, to a 10,000 m(2) (100,000 ft(2)) facility in Ballerup, also a suburb of Copenhagen. Separately, Symphogen announced that Mads Laustsen was appointed to the newly created position of Chief Manufacturing Officer. Mads Laustsen, one of the founders of CMC Biologics, served as the company's CEO from the time of the company's inception 2001 until May 2011, when he was named to the Board of Directors. During this period, the company grew from a business idea to a global leader in contract biologics manufacturing. Laustsen joins Symphogen June 1, but remains a non-executive Director on the CMC Biologics Board. Prior to establishing CMC Biologics, he spent 16 years developing and manufacturing bulk enzymes and biopharmaceuticals at Novo Nordisk, Zymogenetics, and Novozymes. Laustsen has served as a member of various advisory boards, has been active in development of new process technologies, and holds numerous patents in the field.

Symphogen A/S Presents at 8th Annual BIO Europe Spring 2014, Mar-10-2014 09:00 AM

Symphogen A/S Presents at 8th Annual BIO Europe Spring 2014, Mar-10-2014 09:00 AM. Venue: OVAL Lingotto, Turin, Italy. Speakers: Jette Asboe Lassen, Director of Business Development.

Symphogen A/S Presents at The JPMorgan 32nd Annual Healthcare Conference, Jan-14-2014 10:00 AM

Symphogen A/S Presents at The JPMorgan 32nd Annual Healthcare Conference, Jan-14-2014 10:00 AM. Venue: Westin St. Francis Hotel, 335 Powell Street, San Francisco, CA 94102, United States. Speakers: Kirsten Drejer, Co-Founder, Chief Executive Officer and Director.

Similar Private Companies By Industry

Company Name Region
Culture Screening ApS Europe
Direct Haler A/S Europe
Cytotrack ApS Europe
TagAway Devices ApS Europe
Maxygen ApS Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Symphogen A/S, please visit www.symphogen.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.